Dicerna Pharmaceuticals Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/21 Q3

ended 06/30/21 Q2

ended 03/31/21 Q1

ended 12/31/20 FY 2020

ended 09/30/20 Q3

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Post-effective amendment to an automatic shelf registration

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Ownership Filter

Balyasny Asset Management L.P.

Weissman James B

Pagan Douglas W.

News Filter

Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition

Novo Nordisk to Acquire Dicerna

Announces Third Quarter 2021 Financial Results and Provides a Business Update

Announces Second Quarter 2021 Financial Results and Provides a Business Update

Reports Positive Top-Line Results From PHYOX™2 Pivotal Clinical Trial of Nedosiran for the Treatment of Primary Hyperoxaluria

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Confidential treatment order